Chat with GenHealth to automate any coding or chart task.
Name of the Condition
- Progressive Supranuclear Ophthalmoplegia [Steele-Richardson-Olszewski] (ICD-10 Code: G23.1)
Summary
Progressive supranuclear ophthalmoplegia (PSP) is a rare neurodegenerative disorder characterized by progressive loss of voluntary eye movements, particularly vertical gaze, along with postural instability, falls, and cognitive changes. It primarily affects the brainstem and basal ganglia, leading to motor and cognitive decline over time.
Causes
The exact cause of PSP is not fully understood, but it is associated with abnormal accumulation of tau protein in neurons, disrupting cellular function. Genetic factors may play a role in some cases, though most instances are sporadic. Environmental or idiopathic triggers are also considered.
Risk Factors
- Advancing age (typically onset after 60 years).
- Family history of neurodegenerative disorders (in some cases).
- Potential genetic predisposition (though not consistently identified).
Symptoms
- Difficulty moving eyes, especially upward or downward gaze.
- Unsteady gait, frequent falls, and balance problems.
- Slurred speech or swallowing difficulties.
- Cognitive changes, including memory loss or executive dysfunction.
- Stiffness or rigidity in the neck or limbs.
- Behavioral or personality changes.
Diagnosis
Diagnosis involves a clinical evaluation, including neurological exams to assess eye movements, gait, and cognitive function. Imaging (MRI) may show characteristic brain changes, such as midbrain atrophy. Exclusion of other conditions with similar symptoms is key, and response to levodopa may be tested to rule out Parkinson’s disease.
Treatment Options
Management focuses on symptom relief and supportive care. Physical therapy helps with balance and mobility, while speech therapy addresses communication or swallowing issues. Medications may be used to manage rigidity or mood symptoms, though no treatment halts disease progression.
Prognosis and Follow-Up
PSP is progressive, with most patients experiencing worsening symptoms over 5–7 years. Regular follow-up with neurologists and multidisciplinary care (e.g., occupational therapy) is important to address functional decline and quality of life. Palliative care may be considered in advanced stages.
Complications
- Increased risk of falls and fractures due to balance issues.
- Severe swallowing difficulties leading to aspiration or malnutrition.
- Cognitive decline impacting daily functioning.
- Respiratory complications in later stages.
Lifestyle & Prevention
- Fall prevention strategies (e.g., assistive devices, home modifications).
- Regular exercise to maintain mobility and strength.
- Nutritional support to address swallowing challenges.
- Cognitive stimulation activities to support mental function.
When to Seek Professional Help
Seek medical attention if you or a loved one experiences unexplained balance problems, difficulty moving eyes, or progressive motor/cognitive decline. Early evaluation can help distinguish PSP from other treatable conditions.
Tips for Medical Coders
Document the presence of characteristic eye movement abnormalities (e.g., vertical gaze palsy) and associated symptoms (e.g., falls, cognitive changes) to support coding. Ensure documentation aligns with clinical findings, as PSP is often diagnosed clinically with imaging or response to treatment as supporting evidence.
Medical Policies and Guidelines
Related policies from health plans
G23.1 policy automation walkthrough
Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.